CA Participant

Atomo Diagnostics Pty Ltd

Market

Technology

State/Territory

NSW

Location

Drummoyne

Grant Type

Grant Amount

$851,592

Highlights

Contact

Status

Completed
Arrow
Atomo Diagnostics Pty Ltd
Last Reviewed: 16/08/2013

Integrated test device

AtomoRapid is the world's first integrated rapid diagnostic test device. AtomoRapid improves usability and reduces errors in point-of-care settings, by removing the need for complex procedural test kits with multiple components and significant operator handling. Commercialisation Australia's support will enable Atomo to commercialise and launch two AtomoRapid tests in developing markets and secure supply agreements with two leading European diagnostic companies wanting to commercialise existing rapid tests onto the AtomoRapid platform. The Early Stage Commercialisation grant builds on an earlier $250,000 Proof of Concept grant from Commercialisation Australia.

The latest news for Atomo Diagnostics

Atomo a hit at Engineering Excellence Awards 2012

In September 2012 Sydney based health technology company and Commercialisation Australia Participant, Atomo Diagnostics, together with its development partner ide+ won Engineering Excellence Awards for the MicroRapid Integrated Rapid Blood Test Device, the world’s first hand held integrated rapid diagnostic device.

MicroRapid won the Small Business Award, received highly commended recognition in the Innovations & Inventions category and was presented with the prestigious Bradfield Award.

Atomo has received Proof of Concept and Early Stage Commercialisation grants from Commercialisation Australia which enabled it to undertake prototype development with subsequent focus group and international target client review and feedback. The feedback was critical to the improved functional and aesthetic design of the MicroRapid platform.

Atomo aims to bring the detection of a range of diseases out of the laboratory and into homes and outreach clinics across the globe. A test for the rapid detection of HIV is the first clinical application being commercialised using the device and is entering international clinical trials later this year.

Atomo’s MicroRapid device is now on display at Sydney’s Powerhouse Museum, where over a period of twelve months it is expected to be seen by more than four hundred thousand Museum visitors.